Cargando…
T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19
BACKGROUND: In critically ill COVID-19 patients, the initial response to SARS-CoV-2 infection is characterized by major immune dysfunctions. The capacity of these severe patients to mount a robust and persistent SARS-CoV-2 specific T cell response despite the presence of severe immune alterations du...
Autores principales: | Venet, Fabienne, Gossez, Morgane, Bidar, Frank, Bodinier, Maxime, Coudereau, Rémy, Lukaszewicz, Anne-Claire, Tardiveau, Claire, Brengel-Pesce, Karen, Cheynet, Valérie, Cazalis, Marie-Angélique, Pescarmona, Rémi, Garnier, Lorna, Ortillon, Marine, Buisson, Marielle, Bouscambert-Duchamp, Maude, Morfin-Sherpa, Florence, Casalegno, Jean-Sébastien, Conti, Filippo, Rimmelé, Thomas, Argaud, Laurent, Cour, Martin, Saadatian-Elahi, Mitra, Henaff, Laetitia, Vanhems, Philippe, Monneret, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957405/ https://www.ncbi.nlm.nih.gov/pubmed/35349827 http://dx.doi.org/10.1016/j.ebiom.2022.103967 |
Ejemplares similares
-
Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
por: Bidar, Frank, et al.
Publicado: (2022) -
Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
por: Bidar, Frank, et al.
Publicado: (2022) -
Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient
por: Conti, Filippo, et al.
Publicado: (2021) -
Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
por: Venet, Fabienne, et al.
Publicado: (2021) -
A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients
por: Tardiveau, Claire, et al.
Publicado: (2022)